CTTN and the PH domain of BCR partially colocalize in HEK293T cells, suggesting potential phosphorylation of CTTN by ABL as an activation pathway in leukemogenesis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for CTTN-ABL signaling in leukemogenesis; leaves open in vivo validation before any translational consideration.
Chromosomal translocation t(9;22)(q34;q11) leads to generation of different types of the BCR-ABL fusion protein and cause different types of leukemia. The generated fusion proteins differ by the presence or absence of certain domains of BCR -C2, PH, and DH. Mass-spectrometric analysis identified 23 possible interaction partners of PH domain of BCR. Among them is cortactin (CTTN), which is a multidomain protein responsible for the actin branching during endocytosis. The activation of cortactin occurs after phosphorylation by SRC kinase. However, it is unknown whether ABL kinase can phosphorylate and activate CTTN in the same manner. Aim. To demonstrate whether CTTN and PH domains of BCR colocalize in HEK293T cells, to analyze possible phosphorylation sites for the ABL kinase in the cortactin and to make a comparative prediction for SRC kinase. Methods. HEK293T cells were transfected with the engineered pECFP-C3-CTTN and pm-Citrine-C1-PH using a cationic polymer transfection and evaluated with fluorescent microscopy. Putative phosphorylation sites of CTTN by ABL and SRC kinases were predicted by GPS 2.1 software. Results. PH domain and CTTN were expressed in HEK293T cells and show specific cellular colocalization. Phoshorylation sites for ABL kinase (Y384, Y396, Y409, Y416, Y427, Y433, and Y449) were detected in the proline-rich region of CTTN; they match the corresponding sites predicted for SRC kinase. Conclusions. We have shown that CTTN has a cytoplasmic localization; PH domain of BCR was localized predominantly but not exclusively in the nucleus. Their partial colocalization occurs in specific dot-like perinuclear regions. A potential phosphorylation of CTTN by ABL may be one of the activation pathways during leukemogenesis.
No takes yet. Share an insight, caveat, or question.
Gurianov et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: